FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2010/091/001092 [Registered on: 09/09/2010]
Last Modified On: 05/02/2013
Post Graduate Thesis   
Type of Trial   
Type of Study    
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A clinical trial to study the effects of two drugs, Glucosamine 750 mg +Diacerine 50mg + Aceclofenac 100 mg Tablet in patients with osteoarthritis of knee joints. 
Scientific Title of Study   Multicentric, Open label, Randomized, Parallel-group, Active-controlled Clinical trial of the Fixed Dose Combination of Glucosamine 750 mg , Diacerein 50 mg and Aceclofenac 100 mg In patients with osteoarthritis of knee joint. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
JENBURKT/GDA-02/10A  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Nitin M Rathod 
Designation   
Affiliation   
Address  Consulting Physician,Dr R N Cooper Hospital,Ville Parle (West)

Mumbai
MAHARASHTRA
400 056
India 
Phone    
Fax    
Email  nitinmr@yahoo.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Nitin M Rathod 
Designation   
Affiliation   
Address  Consulting Physician,Dr R N Cooper Hospital,Ville Parle (West)

Mumbai
MAHARASHTRA
400 056
India 
Phone    
Fax    
Email  nitinmr@yahoo.in  
 
Details of Contact Person
Public Query
 
Name  Dr Nitin M Rathod 
Designation   
Affiliation   
Address  Consulting Physician,Dr R N Cooper Hospital,Ville Parle (West)

Mumbai
MAHARASHTRA
400 056
India 
Phone    
Fax    
Email  nitinmr@yahoo.in  
 
Source of Monetary or Material Support  
Jenburkt Pharmaceuticals Ltd.Nirmala Apartments, 93, Jayprakash Road, Andheri (West), Mumbai - 400 058. India.  
 
Primary Sponsor  
Name  M/S Jenburkt Pharmaceuticals Ltd.Nirmala Apartments, 93, Jayprakash Road, Andheri (West), Mumbai - 400 058. India.  
Address   
Type of Sponsor   
 
Details of Secondary Sponsor  
Name  Address 
Nil   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 4  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr. Rajiv Oza  Clinic, Bhavnagar, Rajivoza59@hotmail.com  Clinic, Bhavnagar,-
Bhavnagar
GUJARAT 


Rajivoza59@hotmail.com 
Dr Kirti C Patel  KEM Hospital, Mumbai, pkirtic@yahoo.in  KEM Hospital, Mumbai,-
Mumbai
MAHARASHTRA 


pkirtic@yahoo.in 
Dr Nitin M Rathod  RN Cooper Hospital, Mumbai, nitinmr@yahoo.in  RN Cooper Hospital, Mumbai,-
Mumbai
MAHARASHTRA 


nitinmr@yahoo.in 
Dr. Ra G Bhagat  Smt.N.H.L.Muni.Medical College & Hospital,Ahmedabad, Rajpurvi@yahoo.com  Smt.N.H.L.Muni.Medical College & Hospital,Ahmedabad,-
Ahmadabad
GUJARAT 


Rajpurvi@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 4  
Name of Committee  Approval Status 
COMSARTs  Approved 
COMSARTs  Approved 
COMSARTs  Approved 
COMSARTs  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Approved/Obtained 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Osteoarthritis of knee joints,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Diacerine 50mg, Aceclofenac 100 mg Tab  One tab two times a day for 30 days. 
Intervention  Glucosamine 750mg ,Diacerine 50mg ,Aceclofenac 100mg Tab  One Tab two times a dayfor 30 days. 
 
Inclusion Criteria  
Age From   
Age To   
Gender   
Details  All the patients with dully filled Informed Consent Forms ( ICF). Age : 35 to 40 years. Sex : Both male and female. The patients with radiologically defined symptoms of osetoarthritis established diagnosis of osteoarthritis already on analgesic treatment with NSAID ( diclofenac sodium, , Aceclofenac, nimesulide, Naproxen ) not having significant pain relief in terms of pain and disability. 
 
ExclusionCriteria 
Details  Patients with advance disease such as : * Patients with secondary arthritis such as infective, tubercular or psoriatic arthritis. * Patients who had arthroplasty. * Patients having undergone arthroscopic washout of knee joint. * Patients with concomittant diseases such as malignancy, HIV. * Pregnancy nd lactation. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Primary parameters: 1) Pain relief by Visual Analogue scale of 100 millimeters ( VAS) 2. Macgill Questionaire for Pain. 3. Clinical examination for joint pain, stiffness,tenderness and swellings. 4. The range of movement extension by Long-arm Goniometer.  30 days. 
 
Secondary Outcome  
Outcome  TimePoints 
secondery parameters : 1. Quality of Life ( European Q5D) 2. Physician's Global Assessment - 1 to 5 ( Very poor, Poor, Fair, Good and excellent.)  30 days. 
 
Target Sample Size   Total Sample Size="200"
Sample Size from India="" 
Final Enrollment numbers achieved (Total)= ""
Final Enrollment numbers achieved (India)="" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   Date Missing 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  15/07/2010 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years=""
Months="2"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Completed 
Recruitment Status of Trial (India)  Completed 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   This study is a randomised, open label, multicentric trial to compare the efficacy, tolerability and safety of fixed dose combination of " Glucosamine 750 mg, Diacerine 50mg, Aceclofenac 100 mg Vs Diacerine 50 mg and Aceclofenac 100 mg in patients with Osteoarthritis of knee joint that will be conducted in four centres in India. 
Close